To investigate further the transcriptional repression of TIMP3 expression by EZH2, we quantitatively determined TIMP3 mRNA and protein levels in three prostate cancer cell lines (LNCaP, PC3, and DU145) with and without knockdown of EZH2 expression. The gene discussed is EZH2; the disease is prostate cancer.